Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2008-10-15 | Mr. Hopper is the lead director of Polynoma LLC, a private U.S. oncology biotechnology company... Mr. Hopper served as Executive Chairman of Cell Aquaculture Limited and Bone Medical Limited. |
| 2009-10-13 | Mr. Hopper has served as managing director of Cappello Group, Inc., an investment bank... Mr. Hopper served as Executive Chairman of Cell Aquaculture Limited and Bone Medical Limited, drug delivery and aquaculture companies. |
| 2010-10-25 | Mr. Hopper’s over 20 years of experience in international public company markets with sector experience including biotechnology, financial services, nutraceuticals, specialty retail, mining, telecommunications, medical & healthcare services and e-commerce. |
| 2011-10-25 | Mr. Hopper’s over 20 years of experience in international public company markets with sector experience including life sciences, biotechnology, financial services, nutraceuticals, specialty retail, mining, telecommunications, medical & healthcare services and e-commerce, and his focus on start-up and rapid growth companies, both in the U.S. and abroad, provide him with a global perspective on capital markets and financing, and his experience as a director of public companies gives him broad knowledge with respect to corporate governance issues. |
| 2012-10-25 | Mr. Hopper’s over 20 years of experience in international public company markets with sector experience including life sciences, biotechnology, financial services, nutraceuticals, specialty retail, mining, telecommunications, medical & healthcare services and e-commerce, and his focus on start-up and rapid growth companies, both in the U.S. and abroad, provide him with a global perspective on capital markets and financing, and his experience as a director of public companies gives him broad knowledge with respect to corporate governance issues. |
| 2013-10-25 | Mr. Hopper’s over 20 years of experience in international public company markets with sector experience including life sciences, biotechnology, financial services, nutraceuticals, specialty retail, mining, telecommunications, medical & healthcare services and e-commerce, and his focus on start-up and rapid growth companies, both in the U.S. and abroad, provide him with a global perspective on capital markets and financing, and his experience as a director of public companies gives him broad knowledge with respect to corporate governance issues. |
Data sourced from SEC filings. Last updated: 2026-03-05